Skip to main content

Politicians make promises on their stump — we watch and hold them accountable.

Help keep the record honest →Create an account
Bills/119th Congress · House

H.R. 5969

Introduced

LABEL Act

Sponsor
RBarry Moore· Alabama
Introduced
November 7, 2025
Policy area
Health
Latest action
Referred to the House Committee on Energy and Commerce.November 7, 2025

Plain-language analysis

Not yet analyzed.

A plain-language breakdown — including any hidden or off-intent provisions and whether the bill was fast-tracked — is generated separately by AI, and any passage it quotes is checked against the bill text before it can be shown. It will appear here once ready. Until then, the verbatim text below and the official source are the record.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 5969 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 5969 To amend the Federal Food, Drug, and Cosmetic Act to ensure that abortion-inducing drugs bear a label identifying the name and address of the dispenser and the name of the prescriber, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES November 7, 2025 Mr. Moore of Alabama (for himself, Ms. Hageman, Mrs. Miller of Illinois, Mr. McGuire, Mr. Harris of Maryland, Mr. Palmer, Mr. Clyde, and Mr. Pfluger) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to ensure that abortion-inducing drugs bear a label identifying the name and address of the dispenser and the name of the prescriber, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Linking Abortion-drug Batches for Enforcement and Liability Act'' or the ``LABEL Act''. SEC. 2. LABELING REQUIREMENTS FOR ABORTION-INDUCING DRUGS. (a) In General.--Section 503(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353(b)) is amended by adding at the end the following: ``(6)(A) Notwithstanding any other provision of this Act, in the case of an abortion-inducing drug, the drug shall be deemed to be misbranded unless the drug bears a label that identifies-- ``(i) the name and address of the dispenser; and ``(ii) the name of the prescriber. ``(B) No State or political subdivision of a State may establish, continue in effect, or enforce a labeling requirement for an abortion- inducing drug that is not at least as stringent as the labeling requirement in subparagraph (A). ``(C) In this paragraph, the term `abortion-inducing drug'-- ``(i) means a drug that is intended, alone or in combination with 1 or more other drugs, for use or that is in fact used (irrespective of how the drug is labeled) to kill the unborn child of a woman known to be pregnant or to terminate the pregnancy of a woman known to be pregnant; but ``(ii) does not include a drug that is intended, alone or in combination with 1 or more other drugs, for use to remove a dead unborn child of a woman known to be pregnant or to treat an ectopic pregnancy.''. (b) Severability.--If any provision of this section, the amendment made by this section, or the application of such provision or amendment to any person or circumstance is held to be unconstitutional, the remainder of this section, the amendment made by this section, and the application of the provision to such person or circumstance shall not be affected thereby. <all>

StumpWatch is live, and the record is still growing. Many promises and positions aren’t tracked yet, and some features are still in beta. Add a sourced promise and help keep the record honest.

Help keep the record honest →